Published in J Virol on February 01, 1995
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol (1996) 4.15
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol (2000) 2.72
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J (2001) 2.64
The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J Virol (1996) 2.43
Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J Virol (1996) 2.07
Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence. Proc Natl Acad Sci U S A (1997) 1.68
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother (2008) 1.46
Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein. Protein Sci (1997) 1.36
Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes. Proc Natl Acad Sci U S A (1998) 1.24
Mechanistic independence of Nef and cyclophilin A enhancement of human immunodeficiency virus type 1 infectivity. Virology (1998) 1.17
T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1. Antimicrob Agents Chemother (1995) 1.11
Cyclosporine inhibits flavivirus replication through blocking the interaction between host cyclophilins and viral NS5 protein. Antimicrob Agents Chemother (2009) 1.03
Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology (2008) 1.01
Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro. J Virol (1997) 0.99
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res (2004) 0.95
The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells. J Virol (2000) 0.89
Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. J Virol (2001) 0.89
Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target. Drug Target Insights (2007) 0.86
Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity. Eur J Pharmacol (2007) 0.85
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA. Nucleic Acids Res (2004) 0.84
The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes. Biophys J (2004) 0.79
Selection of recombinant, library-derived antibody fragments against p24 for human immunodeficiency virus type 1 diagnostics. Clin Diagn Lab Immunol (1998) 0.79
SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A. J Virol (2017) 0.78
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science (1983) 43.61
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 33.32
Protein folding in the cell. Nature (1992) 19.60
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Correct integration of retroviral DNA in vitro. Cell (1987) 10.73
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature (1993) 10.36
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J Virol (1989) 9.37
HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J (1990) 9.34
Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature (1981) 9.25
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (1989) 8.48
Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science (1984) 8.01
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell (1993) 7.34
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science (1987) 7.22
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A (1992) 6.85
Functional association of cyclophilin A with HIV-1 virions. Nature (1994) 6.82
Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci U S A (1993) 6.44
Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol (1993) 6.11
Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature (1989) 5.86
The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol (1984) 5.80
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (1989) 4.96
Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A (1984) 4.90
The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol (1989) 4.30
Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol (1993) 4.20
Kappa B-specific DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science (1989) 3.48
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation. J Immunol (1987) 3.30
Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol (1985) 3.19
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol (1993) 2.96
Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. Science (1990) 2.59
Differential susceptibility to the acquired immunodeficiency syndrome retrovirus in cloned cells of human leukemic T-cell line Molt-4. J Virol (1986) 2.40
Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J Immunol (1989) 2.13
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98
The effect of cyclosporine A on infection of susceptible cells by human immunodeficiency virus type 1. Blood (1988) 1.56
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc Natl Acad Sci U S A (1992) 1.50
Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res Hum Retroviruses (1994) 1.46
Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator. Proc Natl Acad Sci U S A (1992) 1.45
Inducible nuclear factor binding to the kappa B elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J Virol (1990) 1.21
Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal. J Virol (1994) 1.12
Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phase. J Virol (1994) 1.06
Purification, assay and kinetic features of HIV-1 proteinase. Biol Chem Hoppe Seyler (1990) 1.02
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Kinetics of early HIV-1 gene expression in infected H9 cells assessed by PCR. Oncogene (1991) 0.95
[Functional inhibition by cyclosporin A of the lymphocyte receptor for the AIDS virus (HIV)]. C R Acad Sci III (1986) 0.89
Pharmacology of cyclosporine (sandimmune). I. Introduction. Pharmacol Rev (1990) 0.89
The genomic structure encoding human initiation factor eIF-5A. Gene (1994) 0.84
Measurement of HIV-1 reverse transcriptase by a nonradioactive assay system. Ann N Y Acad Sci (1992) 0.83
Forecasting agriculturally driven global environmental change. Science (2001) 16.70
Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc Natl Acad Sci U S A (1999) 6.81
Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res (1998) 6.11
CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol (1994) 3.48
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Gastric interleukin-8 and IgA IL-8 autoantibodies in Helicobacter pylori infection. Scand J Immunol (1993) 3.22
Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol (1994) 3.16
Electron microscopy of size and shape of viral DNA in solutions of different ionic strengths. J Mol Biol (1967) 3.16
Acupressure and the prevention of nausea and vomiting after laparoscopy. Br J Anaesth (1999) 2.77
BINOCULAR VISION IN MINERS. Br J Ophthalmol (1948) 2.73
Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activation. J Cell Biol (1993) 2.64
Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet (1996) 2.51
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett (1998) 2.49
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother (1994) 2.26
Use of on-line bibliographic retrieval services in health sciences libraries in the United States and Canada. Bull Med Libr Assoc (1979) 2.09
Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry (2005) 2.06
Pollination biology in a lowland dipterocarp forest inSarawak, Malaysia. I. Characteristics of the plant-pollinator communityin a lowland dipterocarp forest. Am J Bot (1998) 2.00
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog. Antimicrob Agents Chemother (1994) 1.98
The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding. Biochem Biophys Res Commun (1992) 1.93
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J Biol Chem (2000) 1.93
Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis (2005) 1.89
Mortality rates in patients with Barrett's oesophagus. Aliment Pharmacol Ther (2007) 1.81
Dehydration of a phosphonate substrate analogue by glycerol 3-phosphate dehydrogenase. Biochem J (1974) 1.80
Metabolic products of microorganisms. 224. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. J Antibiot (Tokyo) (1984) 1.75
Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynaecol (1992) 1.74
The molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replication. J Virol (1996) 1.69
Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology (1998) 1.65
Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin Microbiol Infect (2010) 1.63
Virtual outreach: economic evaluation of joint teleconsultations for patients referred by their general practitioner for a specialist opinion. BMJ (2003) 1.62
Long-term results of pediatric liver transplantation: an analysis of 569 transplants. Ann Surg (1998) 1.59
The cost recovery issue and the governments role in provision of information services. Bull Med Libr Assoc (1982) 1.53
Switchable Polymer Based Thin Film Coils as a Power Module for Wireless Neural Interfaces. Sens Actuators A Phys (2007) 1.52
Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis (2005) 1.51
'What if they ask how I got it?' Dilemmas of disclosing parental HIV status and testing children for HIV in Uganda. Health Policy Plan (2008) 1.50
RANTES is a chemotactic and activating factor for human eosinophils. J Immunol (1993) 1.49
Both Fc receptors and lymphocyte-function-associated antigen 1 on human T gamma lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity). Eur J Immunol (1984) 1.48
Pre-admission clinic in an orthopaedic department: evaluation over a 6-month period. J R Coll Surg Edinb (1998) 1.46
Delayed health hazards of pesticide exposure. Annu Rev Public Health (1986) 1.45
Prosthodontic rehabilitation of midfacial defects. J Prosthet Dent (1985) 1.44
Characterization of a new enterococcal gene, satG, encoding a putative acetyltransferase conferring resistance to Streptogramin A compounds. Antimicrob Agents Chemother (1999) 1.43
Roles for the library in information management. Bull Med Libr Assoc (1982) 1.43
Is sexual risk taking behaviour changing in rural south-west Uganda? Behaviour trends in a rural population cohort 1993-2006. Sex Transm Infect (2009) 1.42
Colo-anal intussusception in an adult: case report and review of the literature. Int J Clin Pract (2009) 1.40
Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups. Eur J Clin Microbiol Infect Dis (2003) 1.38
Congenital ectropion uveae with glaucoma. Ophthalmology (1984) 1.37
The hyaluronan receptor RHAMM regulates extracellular-regulated kinase. J Biol Chem (1998) 1.36
The use of a geographical information system for hospital catchment area research in Natal/KwaZulu. S Afr Med J (1991) 1.34
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut (2003) 1.32
Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis. J Exp Med (1997) 1.31
Some aspects of IL-8 pathophysiology. III: Chemokine interaction with endothelial cells. J Leukoc Biol (1996) 1.30
The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin. J Exp Med (1992) 1.27
Surveillance of work-related asthma in selected U.S. states using surveillance guidelines for state health departments--California, Massachusetts, Michigan, and New Jersey, 1993-1995. MMWR CDC Surveill Summ (1999) 1.27
Behavior in vivo of normal and dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest (1983) 1.26
Activity of fluoro and deoxy analogues of glycerol as substrates and inhibitors of glycerol kinase. Biochem J (1972) 1.26
Extubation failure in a large pediatric ICU population. Chest (2001) 1.25
Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest (1992) 1.25
A microsatellite linkage map for the cultivated strawberry (Fragaria × ananassa) suggests extensive regions of homozygosity in the genome that may have resulted from breeding and selection. Theor Appl Genet (2012) 1.24
Molecular cloning and sequence determination of the genomic regions encoding protease and genome-linked protein of three picornaviruses. J Virol (1986) 1.23
Trafficking of glucose transporters in 3T3-L1 cells. Inhibition of trafficking by phenylarsine oxide implicates a slow dissociation of transporters from trafficking proteins. Biochem J (1992) 1.21
Dehydrogenation of the phosphonate analogue of glucose 6-phosphate by glucose 6-phosphate dehydrogenase. Biochem J (1976) 1.21
Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest (1998) 1.19
Fulminant hepatic failure caused by tuberculosis. Gut (1995) 1.18
Human xanthine oxidase converts nitrite ions into nitric oxide (NO). Biochem Soc Trans (1997) 1.17
Gender and decision-making over condom use in two districts in Uganda. Afr J Reprod Health (2001) 1.17
Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm (2001) 1.16
The neural signal of angular head position in primary afferent vestibular nerve axons. J Physiol (1973) 1.15
[Cryo-ultramicrotomy as a rapid method for electron microscopy]. Mikroskopie (1973) 1.15
Motor evoked potential monitoring during spinal surgery: responses of distal limb muscles to transcranial cortical stimulation with pulse trains. Electroencephalogr Clin Neurophysiol (1996) 1.14
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation. Neuroreport (2001) 1.13
Inferior turbinectomy: comparison of four techniques. J Laryngol Otol (1990) 1.13
Helical model of nucleation and propagation to account for the growth of type I collagen fibrils from symmetrical pointed tips: a special example of self-assembly of rod-like monomers. Proc Natl Acad Sci U S A (1992) 1.12
Drug metabolism in white vegetarians. Br J Clin Pharmacol (1980) 1.12
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia (2010) 1.11
Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome. Dig Dis Sci (1988) 1.11
Histological grading in carcinoma of the breast. Br J Cancer (1966) 1.11
Symmetry and connectivity in the map of the body surface in somatosensory area II of primates. J Neurophysiol (1969) 1.10
An exploratory study of language interpretation services provided by videoconferencing. J Telemed Telecare (2003) 1.10
A new route to peroxynitrite: a role for xanthine oxidoreductase. FEBS Lett (2000) 1.09
Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol (2006) 1.08
The experience of "medicine companions" to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care (2010) 1.07
Pesticide-related illness among migrant farm workers in the United States. Int J Occup Environ Health (2002) 1.07
Respiratory depression in the acute management of seizures. Arch Dis Child (2002) 1.07
The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding. Antiviral Res (1996) 1.06
The third human FER-1-like protein is highly similar to dysferlin. Genomics (2000) 1.06
The ultrafilterable serum magnesium in hyperthyroidism. Biochem J (1942) 1.06
Determination of dissociation and Michaelis constants at near-equal enzyme-substrate concentrations. Anal Biochem (1977) 1.06
Enterococci. Habitats, infections, virulence factors, resistances to antibiotics, transfer of resistance determinants. Contrib Microbiol (2001) 1.06
Do experienced diagnosticians agree about the diagnosis of dementia from survey data? The effects of informants' reports and interviewers' vignettes. Int J Geriatr Psychiatry (1998) 1.05
Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action. J Immunol (2001) 1.05
Early childhood malnutrition predicts depressive symptoms at ages 11-17. J Child Psychol Psychiatry (2010) 1.05
Methodological lessons from a cohort study of high risk women in Tanzania. Sex Transm Infect (2004) 1.05